{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:48:59Z","timestamp":1793713739860,"version":"4.6.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["PCI08086"],"award-info":[{"award-number":["PCI08086"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R42AL104034-03A1"],"award-info":[{"award-number":["R42AL104034-03A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG000216"],"award-info":[{"award-number":["AG000216"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000925","name":"John Templeton Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS072031"],"award-info":[{"award-number":["NS072031"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Bundy Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13195-017-0277-3","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T11:04:01Z","timestamp":1500030241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["A novel Alzheimer\u2019s disease drug candidate targeting inflammation and fatty acid metabolism"],"prefix":"10.1186","volume":"9","author":[{"given":"Daniel","family":"Daugherty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Dargusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"issue":"12","key":"277_CR1","doi-asserted-by":"publisher","first-page":"e27865","DOI":"10.1371\/journal.pone.0027865","volume":"6","author":"Q Chen","year":"2011","unstructured":"Chen Q, Prior M, Dargusch R, Roberts A, Riek R, Eichmann C, et al. A novel neurotrophic drug for cognitive enhancement and Alzheimer\u2019s disease. PLoS One. 2011;6(12):e27865.","journal-title":"PLoS One"},{"issue":"3","key":"277_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/alzrt179","volume":"5","author":"M Prior","year":"2013","unstructured":"Prior M, Dargusch R, Ehren JL, Chiruta C, Schubert D. The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer\u2019s disease mice. Alzheimers Res Ther. 2013;5(3):25.","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"277_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1021\/cn500051h","volume":"5","author":"M Prior","year":"2014","unstructured":"Prior M, Chiruta C, Currais A, Goldberg J, Dargusch R, Maher P, et al. Back to the future with phenotypic screening. ACS Chem Neurosci. 2014;5(7):503\u201313.","journal-title":"ACS Chem Neurosci"},{"issue":"6","key":"277_CR4","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jalz.2016.03.016","volume":"12","author":"M Prior","year":"2016","unstructured":"Prior M, Goldberg J, Chiruta C, Farrokhi C, Kopynets M, Roberts AJ, et al. Selecting for neurogenic potential as an alternative for Alzheimer\u2019s disease drug discovery. Alzheimers Dement. 2016;12(6):678\u201386.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"277_CR5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.18632\/aging.100838","volume":"7","author":"A Currais","year":"2015","unstructured":"Currais A, Goldberg J, Farrokhi C, Chang M, Prior M, Dargusch R, et al. A comprehensive multiomics approach toward understanding the relationship between aging and dementia. Aging. 2015;7(11):937\u201355.","journal-title":"Aging"},{"issue":"3","key":"277_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neulet.2005.02.017","volume":"381","author":"D Olin","year":"2005","unstructured":"Olin D, MacMurray J, Comings DE. Risk of late-onset Alzheimer\u2019s disease associated with BDNF C270T polymorphism. Neurosci Lett. 2005;381(3):275\u20138.","journal-title":"Neurosci Lett"},{"issue":"12","key":"277_CR7","doi-asserted-by":"publisher","first-page":"e355","DOI":"10.1371\/journal.pmed.0020355","volume":"2","author":"JL Jankowsky","year":"2005","unstructured":"Jankowsky JL, Slunt HH, Gonzales V, Savonenko AV, Wen JC, Jenkins NA, et al. Persistent amyloidosis following suppression of A\u03b2 production in a transgenic model of Alzheimer disease. PLoS Med. 2005;2(12):e355.","journal-title":"PLoS Med"},{"issue":"2","key":"277_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbr.2008.09.002","volume":"196","author":"M Gulinello","year":"2009","unstructured":"Gulinello M, Gertner M, Mendoza G, Schoenfeld BP, Oddo S, LaFerla F, et al. Validation of a 2-day water maze protocol in mice. Behav Brain Res. 2009;196(2):220\u20137.","journal-title":"Behav Brain Res"},{"issue":"1-2","key":"277_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0166-4328(01)00291-1","volume":"125","author":"C Belzung","year":"2001","unstructured":"Belzung C, Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res. 2001;125(1-2):141\u20139.","journal-title":"Behav Brain Res"},{"issue":"2","key":"277_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/BF00177912","volume":"92","author":"RG Lister","year":"1987","unstructured":"Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 1987;92(2):180\u20135.","journal-title":"Psychopharmacology"},{"key":"277_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.ne.17.030194.002511","volume":"17","author":"RF Thompson","year":"1994","unstructured":"Thompson RF, Krupa DJ. Organization of memory traces in the mammalian brain. Annu Rev Neurosci. 1994;17:519\u201349.","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"277_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.neubiorev.2005.06.005","volume":"30","author":"JJ Kim","year":"2006","unstructured":"Kim JJ, Jung MW. Neural circuits and mechanisms involved in Pavlovian fear conditioning: a critical review. Neurosci Biobehav Rev. 2006;30(2):188\u2013202.","journal-title":"Neurosci Biobehav Rev"},{"issue":"34","key":"277_CR13","doi-asserted-by":"publisher","first-page":"8702","DOI":"10.1523\/JNEUROSCI.1742-06.2006","volume":"26","author":"DA Bangasser","year":"2006","unstructured":"Bangasser DA, Waxler DE, Santollo J, Shors TJ. Trace conditioning and the hippocampus: the importance of contiguity. J Neurosci. 2006;26(34):8702\u20136.","journal-title":"J Neurosci"},{"issue":"2","key":"277_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0896-6273(00)80041-0","volume":"16","author":"S Maren","year":"1996","unstructured":"Maren S, Fanselow MS. The amygdala and fear conditioning: has the nut been cracked? Neuron. 1996;16(2):237\u201340.","journal-title":"Neuron"},{"issue":"4","key":"277_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0092-8674(00)81247-7","volume":"85","author":"MT Rogan","year":"1996","unstructured":"Rogan MT, LeDoux JE. Emotion: systems, cells, synaptic plasticity. Cell. 1996;85(4):469\u201375.","journal-title":"Cell"},{"issue":"1","key":"277_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W da Huang","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357.","journal-title":"Nat Protoc"},{"issue":"4","key":"277_CR17","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/j.1471-4159.2008.05236.x","volume":"105","author":"Y Liu","year":"2008","unstructured":"Liu Y, Dargusch R, Maher P, Schubert D. A broadly neuroprotective derivative of curcumin. J Neurochem. 2008;105(4):1336\u201345.","journal-title":"J Neurochem"},{"issue":"6","key":"277_CR18","doi-asserted-by":"publisher","first-page":"698","DOI":"10.2174\/138161210790883741","volume":"16","author":"C Lanni","year":"2010","unstructured":"Lanni C, Stanga S, Racchi M, Govoni S. The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders. Curr Pharm Des. 2010;16(6):698\u2013717.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"277_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1254\/jjp.53.221","volume":"53","author":"K Abe","year":"1990","unstructured":"Abe K, Takayanagi M, Saito H. Effects of recombinant human basic fibroblast growth factor and its modified protein CS23 on survival of primary cultured neurons from various regions of fetal rat brain. Jpn J Pharmacol. 1990;53(2):221\u20137.","journal-title":"Jpn J Pharmacol"},{"issue":"5","key":"277_CR20","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1046\/j.1471-4159.2003.02255.x","volume":"88","author":"OG Rossler","year":"2004","unstructured":"Rossler OG, Giehl KM, Thiel G. Neuroprotection of immortalized hippocampal neurones by brain-derived neurotrophic factor and Raf-1 protein kinase: role of extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase. J Neurochem. 2004;88(5):1240\u201352.","journal-title":"J Neurochem"},{"issue":"2","key":"277_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1042\/CS20050163","volume":"110","author":"MV Chao","year":"2006","unstructured":"Chao MV, Rajagopal R, Lee FS. Neurotrophin signalling in health and disease. Clin Sci (Lond). 2006;110(2):167\u201373.","journal-title":"Clin Sci (Lond)"},{"key":"277_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainres.2008.08.080","volume":"1241","author":"Y Nakajo","year":"2008","unstructured":"Nakajo Y, Miyamoto S, Nakano Y, Xue JH, Hori T, Yanamoto H. Genetic increase in brain-derived neurotrophic factor levels enhances learning and memory. Brain Res. 2008;1241:103\u20139. A published erratum appears in Brain Res. 2009;1263:192.","journal-title":"Brain Res"},{"issue":"5","key":"277_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1517\/14728222.8.5.391","volume":"8","author":"S Pezet","year":"2004","unstructured":"Pezet S, Malcangio M. Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opin Ther Targets. 2004;8(5):391\u20139.","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"277_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2174\/1568026013394741","volume":"1","author":"S Tan","year":"2001","unstructured":"Tan S, Schubert D, Maher P. Oxytosis: a novel form of programmed cell death. Curr Topics Med Chem. 2001;1(6):497\u2013506.","journal-title":"Curr Topics Med Chem"},{"key":"277_CR25","first-page":"189","volume-title":"Micronutrients and brain health","author":"P Maher","year":"2010","unstructured":"Maher P. Modulation of multiple pathways involved in the maintenance of neuronal function by fisetin. In: Parker L, Sies H, Eggersdorfer M, Cardenas E, editors. Micronutrients and brain health. Boca Raton, FL: CRC Press; 2010. p. 189\u2013206."},{"key":"277_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.brainres.2007.07.061","volume":"1173","author":"P Maher","year":"2007","unstructured":"Maher P, Salgado KF, Zivin JA, Lapchak PA. A novel approach to screening for new neuroprotective compounds for the treatment of stroke. Brain Res. 2007;1173:117\u201325.","journal-title":"Brain Res"},{"issue":"6","key":"277_CR27","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0092-8674(94)90131-7","volume":"77","author":"C Behl","year":"1994","unstructured":"Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid \u03b2 protein toxicity. Cell. 1994;77(6):817\u201327.","journal-title":"Cell"},{"issue":"10","key":"277_CR28","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.15252\/embr.201642195","volume":"17","author":"K Pakos-Zebrucka","year":"2016","unstructured":"Pakos-Zebrucka K, Koryga I, Mnich K, Ljujic M, Samali A, Gorman AM. The integrated stress response. EMBO Rep. 2016;17(10):1374\u201395.","journal-title":"EMBO Rep"},{"issue":"5","key":"277_CR29","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1083\/jcb.152.5.997","volume":"152","author":"S Tan","year":"2001","unstructured":"Tan S, Somia N, Maher P, Schubert D. Regulation of antioxidant metabolism by translation initiation factor-2\u03b1. J Cell Biol. 2001;152(5):997\u20131006.","journal-title":"J Cell Biol"},{"issue":"2","key":"277_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4161\/auto.5269","volume":"4","author":"A Simonsen","year":"2008","unstructured":"Simonsen A, Cumming RC, Brech A, Isakson P, Schubert DR, Finley KD. Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila. Autophagy. 2008;4(2):176\u201384.","journal-title":"Autophagy"},{"issue":"Suppl","key":"277_CR31","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1194\/jlr.R800079-JLR200","volume":"50","author":"SJ Wakil","year":"2009","unstructured":"Wakil SJ, Abu-Elheiga LA. Fatty acid metabolism: target for metabolic syndrome. J Lipid Res. 2009;50(Suppl):S138\u201343.","journal-title":"J Lipid Res"},{"issue":"13","key":"277_CR32","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1001\/jama.2011.381","volume":"305","author":"EM Schrijvers","year":"2011","unstructured":"Schrijvers EM, Koudstaal PJ, Hofman A, Breteler MM. Plasma clusterin and the risk of Alzheimer disease. JAMA. 2011;305(13):1322\u20136.","journal-title":"JAMA"},{"issue":"1","key":"277_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1096\/fj.201601184","volume":"31","author":"A Currais","year":"2017","unstructured":"Currais A, Fischer W, Maher P, Schubert D. Intraneuronal protein aggregation as a trigger for inflammation and neurodegeneration in the aging brain. FASEB J. 2017;31(1):5\u201310.","journal-title":"FASEB J"},{"key":"277_CR34","doi-asserted-by":"publisher","first-page":"16012","DOI":"10.1038\/npjamd.2016.12","volume":"2","author":"A Currais","year":"2016","unstructured":"Currais A, Quehenberger O, Armando AM, Daugherty D, Maher P, Schubert D. Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids. NPJ Aging Mech Dis. 2016;2:16012.","journal-title":"NPJ Aging Mech Dis"},{"issue":"25","key":"277_CR35","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.1523\/JNEUROSCI.5183-12.2013","volume":"33","author":"E Valera","year":"2013","unstructured":"Valera E, Dargusch R, Maher PA, Schubert D. Modulation of 5-lipoxygenase in proteotoxicity and Alzheimer\u2019s disease. J Neurosci. 2013;33(25):10512\u201325.","journal-title":"J Neurosci"},{"issue":"Pt B","key":"277_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cca.2015.06.021","volume":"451","author":"L Ma","year":"2015","unstructured":"Ma L, Li Y, Wang R. Drebrin and cognitive impairment. Clin Chim Acta. 2015;451(Pt B):121\u20134.","journal-title":"Clin Chim Acta"},{"key":"277_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fnmol.2015.00078","volume":"8","author":"K Minatohara","year":"2016","unstructured":"Minatohara K, Akiyoshi M, Okuno H. Role of immediate-early genes in synaptic plasticity and neuronal ensembles underlying the memory trace. Front Mol Neurosci. 2016;8:78.","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"277_CR38","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1023\/A:1005621125812","volume":"32","author":"RJ Devenish","year":"2000","unstructured":"Devenish RJ, Prescott M, Boyle GM, Nagley P. The oligomycin axis of mitochondrial ATP synthase: OSCP and the proton channel. J Bioenerg Biomembr. 2000;32(5):507\u201315.","journal-title":"J Bioenerg Biomembr"},{"issue":"6","key":"277_CR39","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/ng.2982","volume":"46","author":"SY Shin","year":"2014","unstructured":"Shin SY, Fauman EB, Petersen AK, Krumsiek J, Santos R, Huang J, et al. An atlas of genetic influences on human blood metabolites. Nat Genet. 2014;46(6):543\u201350.","journal-title":"Nat Genet"},{"issue":"1","key":"277_CR40","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1021\/jm2012563","volume":"55","author":"C Chiruta","year":"2012","unstructured":"Chiruta C, Schubert D, Dargusch R, Maher P. Chemical modification of the multitarget neuroprotective compound fisetin. J Med Chem. 2012;55(1):378\u201389.","journal-title":"J Med Chem"},{"issue":"8","key":"277_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.tins.2010.05.004","volume":"33","author":"KR Zahs","year":"2010","unstructured":"Zahs KR, Ashe KH. \u2018Too much good news\u2019 \u2013 are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer\u2019s disease? Trends Neurosci. 2010;33(8):381\u20139.","journal-title":"Trends Neurosci"},{"issue":"3","key":"277_CR42","first-page":"223","volume":"15","author":"KA Wollen","year":"2010","unstructured":"Wollen KA. Alzheimer\u2019s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Altern Med Rev. 2010;15(3):223\u201344.","journal-title":"Altern Med Rev"},{"issue":"3","key":"277_CR43","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.nbd.2004.10.022","volume":"18","author":"A Savonenko","year":"2005","unstructured":"Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, et al. Episodic-like memory deficits in the APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease: relationships to \u03b2-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis. 2005;18(3):602\u201317.","journal-title":"Neurobiol Dis"},{"issue":"5868","key":"277_CR44","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/297681a0","volume":"297","author":"RG Morris","year":"1982","unstructured":"Morris RG, Garrud P, Rawlins JN, O\u2019Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 1982;297(5868):681\u20133.","journal-title":"Nature"},{"issue":"7","key":"277_CR45","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1523\/JNEUROSCI.2984-08.2009","volume":"29","author":"WJ Meilandt","year":"2009","unstructured":"Meilandt WJ, Cisse M, Ho K, Wu T, Esposito LA, Scearce-Levie K, et al. Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic A\u03b2 oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice. J Neurosci. 2009;29(7):1977\u201386.","journal-title":"J Neurosci"},{"issue":"5825","key":"277_CR46","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, et al. Reducing endogenous tau ameliorates amyloid \u03b2-induced deficits in an Alzheimer\u2019s disease mouse model. Science. 2007;316(5825):750\u20134.","journal-title":"Science"},{"key":"277_CR47","doi-asserted-by":"publisher","unstructured":"Zenaro E, Piacentino G, Constantin G. The blood-brain barrier in Alzheimer\u2019s disease. Neurobiol Dis. doi:\n                    10.1016\/j.nbd.2016.07.007\n                    \n                  .","DOI":"10.1016\/j.nbd.2016.07.007"},{"issue":"6","key":"277_CR48","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1089\/ars.2010.3522","volume":"15","author":"JM Cook-Mills","year":"2011","unstructured":"Cook-Mills JM, Marchese ME, Abdala-Valencia H. Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxid Redox Signal. 2011;15(6):1607\u201338.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"277_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.exger.2009.09.005","volume":"45","author":"M Ewers","year":"2010","unstructured":"Ewers M, Mielke MM, Hampel H. Blood-based biomarkers of microvascular pathology in Alzheimer\u2019s disease. Exp Gerontol. 2010;45(1):75\u20139.","journal-title":"Exp Gerontol"},{"issue":"4","key":"277_CR50","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3233\/JAD-2009-1030","volume":"16","author":"SD Yan","year":"2009","unstructured":"Yan SD, Bierhaus A, Nawroth PP, Stern DM. RAGE and Alzheimer\u2019s disease: a progression factor for amyloid-\u03b2-induced cellular perturbation? J Alzheimers Dis. 2009;16(4):833\u201343.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"277_CR51","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainresrev.2009.05.007","volume":"61","author":"T Nuutinen","year":"2009","unstructured":"Nuutinen T, Suuronen T, Kauppinen A, Salminen A. Clusterin: a forgotten player in Alzheimer\u2019s disease. Brain Res Rev. 2009;61(2):89\u2013104.","journal-title":"Brain Res Rev"},{"issue":"7","key":"277_CR52","doi-asserted-by":"publisher","first-page":"e103351","DOI":"10.1371\/journal.pone.0103351","volume":"9","author":"JC Won","year":"2014","unstructured":"Won JC, Park CY, Oh SW, Lee ES, Youn BS, Kim MS. Plasma clusterin (ApoJ) levels are associated with adiposity and systemic inflammation. PLoS One. 2014;9(7):e103351.","journal-title":"PLoS One"},{"issue":"4","key":"277_CR53","first-page":"247","volume":"2","author":"K Endres","year":"2013","unstructured":"Endres K, Reinhardt S. ER-stress in Alzheimer\u2019s disease: turning the scale? Am J Neurodegener Dis. 2013;2(4):247\u201365.","journal-title":"Am J Neurodegener Dis"},{"issue":"3","key":"277_CR54","doi-asserted-by":"publisher","first-page":"F226","DOI":"10.1152\/ajprenal.00495.2014","volume":"308","author":"H Kim","year":"2015","unstructured":"Kim H, Moon SY, Kim JS, Baek CH, Kim M, Min JY, et al. Activation of AMP-activated protein kinase inhibits ER stress and renal fibrosis. Am J Physiol Renal Physiol. 2015;308(3):F226\u201336.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"277_CR55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3940(02)00210-0","volume":"324","author":"KS Shim","year":"2002","unstructured":"Shim KS, Lubec G. Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer\u2019s disease and Down syndrome. Neurosci Lett. 2002;324(3):209\u201312.","journal-title":"Neurosci Lett"},{"issue":"2","key":"277_CR56","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00221-009-1959-2","volume":"200","author":"CR Bramham","year":"2010","unstructured":"Bramham CR, Alme MN, Bittins M, Kuipers SD, Nair RR, Pai B, et al. The Arc of synaptic memory. Exp Brain Res. 2010;200(2):125\u201340.","journal-title":"Exp Brain Res"},{"issue":"10","key":"277_CR57","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/nn.3199","volume":"15","author":"N Rudinskiy","year":"2012","unstructured":"Rudinskiy N, Hawkes JM, Betensky RA, Eguchi M, Yamaguchi S, Spires-Jones TL, et al. Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer\u2019s disease. Nat Neurosci. 2012;15(10):1422\u20139.","journal-title":"Nat Neurosci"},{"key":"277_CR58","doi-asserted-by":"publisher","first-page":"11483","DOI":"10.1038\/ncomms11483","volume":"7","author":"SJ Beck","year":"2016","unstructured":"Beck SJ, Guo L, Phensy A, Tian J, Wang L, Tandon N, et al. Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer\u2019s disease. Nat Commun. 2016;7:11483.","journal-title":"Nat Commun"},{"issue":"2","key":"277_CR59","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.brainresrev.2008.09.002","volume":"59","author":"M Maalouf","year":"2009","unstructured":"Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev. 2009;59(2):293\u2013315.","journal-title":"Brain Res Rev"},{"issue":"1","key":"277_CR60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.plipres.2009.08.004","volume":"49","author":"LL Jones","year":"2010","unstructured":"Jones LL, McDonald DA, Borum PR. Acylcarnitines: role in brain. Prog Lipid Res. 2010;49(1):61\u201375.","journal-title":"Prog Lipid Res"},{"key":"277_CR61","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1196\/annals.1344.013","volume":"1053","author":"SA Zanelli","year":"2005","unstructured":"Zanelli SA, Solenski NJ, Rosenthal RE, Fiskum G. Mechanisms of ischemic neuroprotection by acetyl-l-carnitine. Ann N Y Acad Sci. 2005;1053:153\u201361.","journal-title":"Ann N Y Acad Sci"},{"key":"277_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","volume":"108","author":"Z Chen","year":"2013","unstructured":"Chen Z, Zhong C. Decoding Alzheimer\u2019s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol. 2013;108:21\u201343.","journal-title":"Prog Neurobiol"},{"key":"277_CR63","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2051-5960-2-9","volume":"2","author":"TA Couttas","year":"2014","unstructured":"Couttas TA, Kain N, Daniels B, Lim XY, Shepherd C, Kril J, et al. Loss of the neuroprotective factor sphingosine 1-phosphate early in Alzheimer\u2019s disease pathogenesis. Acta Neuropathol Commun. 2014;2:9.","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"277_CR64","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","volume":"31","author":"X He","year":"2010","unstructured":"He X, Huang Y, Li B, Gong CX, Schuchman EH. Deregulation of sphingolipid metabolism in Alzheimer\u2019s disease. Neurobiol Aging. 2010;31(3):398\u2013408.","journal-title":"Neurobiol Aging"},{"key":"277_CR65","unstructured":"Wake Forest University Health Sciences. Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer\u2019s Disease (BEAM). ClinicalTrials.gov identifier: NCT02984540. Registered on 30 Nov 2016."},{"issue":"9","key":"277_CR66","doi-asserted-by":"publisher","first-page":"707","DOI":"10.18632\/aging.100690","volume":"6","author":"DE Bredesen","year":"2014","unstructured":"Bredesen DE. Reversal of cognitive decline: a novel therapeutic program. Aging (Albany NY). 2014;6(9):707\u201317.","journal-title":"Aging (Albany NY)"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-017-0277-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-017-0277-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-017-0277-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T11:28:25Z","timestamp":1589542105000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-017-0277-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["277"],"URL":"https:\/\/doi.org\/10.1186\/s13195-017-0277-3","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,14]]},"assertion":[{"value":"22 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"50"}}